These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17176481)

  • 1. HIV seroprevalence among participants at a Supervised Injection Facility in Vancouver, Canada: implications for prevention, care and treatment.
    Tyndall MW; Wood E; Zhang R; Lai C; Montaner JS; Kerr T
    Harm Reduct J; 2006 Dec; 3():36. PubMed ID: 17176481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility.
    Wood E; Kerr T; Stoltz J; Qui Z; Zhang R; Montaner JS; Tyndall MW
    Public Health; 2005 Dec; 119(12):1111-5. PubMed ID: 16214189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.
    Reddon H; Wood E; Tyndall M; Lai C; Hogg R; Montaner J; Kerr T
    AIDS Educ Prev; 2011 Oct; 23(5):412-22. PubMed ID: 22010805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a medically supervised injection facility among street youth.
    Hadland SE; DeBeck K; Kerr T; Nguyen P; Simo A; Montaner JS; Wood E
    J Adolesc Health; 2014 Nov; 55(5):684-9. PubMed ID: 24925493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
    Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
    Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.
    Milloy MJ; Kerr T; Mathias R; Zhang R; Montaner JS; Tyndall M; Wood E
    Am J Drug Alcohol Abuse; 2008; 34(4):499-509. PubMed ID: 18584579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
    Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
    Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility.
    Fast D; Small W; Wood E; Kerr T
    Harm Reduct J; 2008 Oct; 5():32. PubMed ID: 18957139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
    Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
    Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Condom use among injection drug users accessing a supervised injecting facility.
    Marshall BD; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
    Sex Transm Infect; 2009 Apr; 85(2):121-6. PubMed ID: 18812391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of on-site detoxification services co-located with a supervised injection facility.
    Gaddis A; Kennedy MC; Nosova E; Milloy MJ; Hayashi K; Wood E; Kerr T
    J Subst Abuse Treat; 2017 Nov; 82():1-6. PubMed ID: 29021106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do supervised injecting facilities attract higher-risk injection drug users?
    Wood E; Tyndall MW; Li K; Lloyd-Smith E; Small W; Montaner JS; Kerr T
    Am J Prev Med; 2005 Aug; 29(2):126-30. PubMed ID: 16005809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facility.
    DeBeck K; Wood E; Zhang R; Tyndall M; Montaner J; Kerr T
    Subst Abuse Treat Prev Policy; 2008 May; 3():11. PubMed ID: 18462491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility.
    Wood E; Tyndall MW; Qui Z; Zhang R; Montaner JS; Kerr T
    Am J Public Health; 2006 May; 96(5):770-3. PubMed ID: 16571703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture.
    Small W; Shoveller J; Moore D; Tyndall M; Wood E; Kerr T
    Qual Health Res; 2011 Jun; 21(6):743-56. PubMed ID: 21378259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
    Spittal PM; Craib KJ; Wood E; Laliberté N; Li K; Tyndall MW; O'Shaughnessy MV; Schechter MT
    CMAJ; 2002 Apr; 166(7):894-9. PubMed ID: 11949985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
    Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for evaluating North America's first medically supervised safer-injecting facility.
    Wood E; Kerr T; Montaner JS; Strathdee SA; Wodak A; Hankins CA; Schechter MT; Tyndall MW
    Lancet Infect Dis; 2004 May; 4(5):301-6. PubMed ID: 15120347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection drug use cessation and use of North America's first medically supervised safer injecting facility.
    DeBeck K; Kerr T; Bird L; Zhang R; Marsh D; Tyndall M; Montaner J; Wood E
    Drug Alcohol Depend; 2011 Jan; 113(2-3):172-6. PubMed ID: 20800976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.